RBBP4, known to modulate MRN, a complex containing Mre11a, has been found to negatively correlate with both CD56dim and CD56bright NK cell infiltration in non-small cell lung cancer (NSCLC) [130]. Here, RBBP4 is linked to non-small cell lung carcinoma.